The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Landscape of kinase rearrangements (kRE) detected in circulating tumor DNA (ctDNA).
 
Ben C. Creelan
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene
Speakers' Bureau - ARIAD; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Daniel S Lieber
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Alexa Betzig Schrock
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Russell Madison
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Jeffrey S. Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Jared White
Employment - Foundation Medicine
 
Vincent A. Miller
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center
 
Samuel Jacob Klempner
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Lilly
Speakers' Bureau - Foundation Medicine
Research Funding - Leap Therapeutics (Inst)
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - TP Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Foundation Medicine; Genentech/Roche; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Foundation Medicine; Ignyta; Novartis; Pfizer; Roche/Genentech; Takeda; TP Therapeutics
Speakers' Bureau - AstraZeneca; Genentech; Takeda
Research Funding - ARIAD (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Chugai Pharma (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
 
Doron Lipson
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Jon Chung
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Allison W. Welsh
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Travel, Accommodations, Expenses - Foundation Medicine
 
Siraj Mahamed Ali
Employment - Foundation Medicine; Foundation Medicine
Stock and Other Ownership Interests - Agios; Blueprint Medicines; Exelixis
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I)